MARKET NEWS

Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products
MediciNova Announces Opening of IND for MN-166  for Prevention of Acute Respiratory Distress Syndrome in Patients With COVID-19
Avadel Announces Sale of Hospital Sterile Injectable Drug Portfolio for $42 Million

  FEATURED EDITORIAL

  COMPANY PROFILE

Headquartered in Nashville,TN PMI BioPharma Solutions is a team of highly experienced life science experts providing rigorous research, pharmaceutical development, and clinical manufacturing services to clients in the pharmaceutical and biotechnology space. We pride ourselves on our abilities, integrity, and persistence in the face of challenge, and will exert maximal effort and ingenuity to achieve your goals. Click here for more.

  EXCLUSIVE ONLINE CONTENT

IM Therapeutics Announces First Patient Dosed in Phase 1 Study of its Lead Drug for Type 1 Diabetes

IM Therapeutics Announces First Patient Dosed in Phase 1 Study of its Lead Drug for Type 1 Diabetes

ImmunoMolecular Therapeutics, Inc. recently announced the dosing of the first patient in a Phase 1 study of IMT-002, an oral small molecule drug designed as a selective….

Timber Pharmaceuticals Announces All CONTROL Study Sites Open & Enrolling Patients With Moderate-to-Severe Congenital Ichthyosis

Timber Pharmaceuticals Announces All CONTROL Study Sites Open & Enrolling Patients With Moderate-to-Severe Congenital Ichthyosis

Timber Pharmaceuticals, Inc. recently announced that all 11 sites across the US and Australia participating in the Phase 2b CONTROL study evaluating TMB-001 (topical isotretinoin) are now….

Big Bio/Pharma Companies' Sales Bolstered by COVID-19

Big Bio/Pharma Companies' Sales Bolstered by COVID-19

The COVID-19 pandemic has led to temporarily increased drug sales for biggest bio/pharma companies in the first quarter (Q1) of 2020. This increase over sales forecasts….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

July 22 – Bioavailability
July 29 – Excipients